{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T00:22:51Z","timestamp":1720657371889},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,10]]},"DOI":"10.7759\/cureus.64251","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T15:45:21Z","timestamp":1720626321000},"source":"Crossref","is-referenced-by-count":0,"title":["Metformin-Induced Nightmares: An Uncommon Event"],"prefix":"10.7759","author":[{"given":"Bosky","family":"Modi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devi P","family":"Suravajjala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Case","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priya","family":"Velumani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2337\/cd21-0043","article-title":"Recommendations for practical use of metformin, a central pharmacological therapy in type 2 diabetes","volume":"40","author":"Vieira IH","year":"2022","unstructured":"Vieira IH, Barros LM, Baptista CF, Rodrigues DM, Paiva IM. Recommendations for practical use of metformin, a central pharmacological therapy in type 2 diabetes. Clin Diabetes. 2022, 40:97-107. 10.2337\/cd21-0043","journal-title":"Clin Diabetes"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.3805","article-title":"Metformin in 2019","volume":"321","author":"Flory J","year":"2019","unstructured":"Flory J, Lipska K. Metformin in 2019. JAMA. 2019, 321:1926-7. 10.1001\/jama.2019.3805","journal-title":"JAMA"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4336-x","article-title":"Metformin: clinical use in type 2 diabetes","volume":"60","author":"Sanchez-Rangel E","year":"2017","unstructured":"Sanchez-Rangel E, Inzucchi SE. Metformin: clinical use in type 2 diabetes. Diabetologia. 2017, 60:1586-93. 10.1007\/s00125-017-4336-x","journal-title":"Diabetologia"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnaa023","article-title":"Cellular and molecular mechanisms of metformin action","volume":"42","author":"LaMoia TE","year":"2021","unstructured":"LaMoia TE, Shulman GI. Cellular and molecular mechanisms of metformin action. Endocr Rev. 2021, 42:77-96. 10.1210\/endrev\/bnaa023","journal-title":"Endocr Rev"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c2181","article-title":"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial","volume":"340","author":"de Jager J","year":"2010","unstructured":"de Jager J, Kooy A, Lehert P, et al.. Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial. Br Med J. 2010, 340:10.1136\/bmj.c2181","journal-title":"Br Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/2230-8210.94262","article-title":"Metformin and sleep disorders","volume":"16","author":"Wiwanitkit S","year":"2012","unstructured":"Wiwanitkit S, Wiwanitkit V. Metformin and sleep disorders. Indian J Endocrinol Metab. 2012, 16:63-4. 10.4103\/2230-8210.94262","journal-title":"Indian J Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2007.07.017","article-title":"Association between sleep duration and hemoglobin A1c level","volume":"9","author":"Nakajima H","year":"2008","unstructured":"Nakajima H, Kaneita Y, Yokoyama E, et al.. Association between sleep duration and hemoglobin A1c level. Sleep Med. 2008, 9:745-52. 10.1016\/j.sleep.2007.07.017","journal-title":"Sleep Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(85)91537-9","article-title":"Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming","volume":"327","author":"Heiss WD","year":"1985","unstructured":"Heiss WD, Pawlik G, Herholz K, Wagner R, Wienhard K. Regional cerebral glucose metabolism in man during wakefulness, sleep, and dreaming. Brain Res. 1985, 327:362-6. 10.1016\/0006-8993(85)91537-9","journal-title":"Brain Res"},{"key":"ref9","unstructured":"National diabetes statistics report. estimates of diabetes and its burden in the United States. (2022). https:\/\/stacks.cdc.gov\/view\/cdc\/85309."},{"key":"ref10","article-title":"Metformin: current knowledge","volume":"19","author":"Nasri H","year":"2014","unstructured":"Nasri H, Rafieian-Kopaei M. Metformin: current knowledge. J Res Med Sci. 2014, 19:658-64.","journal-title":"J Res Med Sci"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S409373","article-title":"Metformin: a review of potential mechanism and therapeutic utility beyond diabetes","volume":"17","author":"Dutta S","year":"2023","unstructured":"Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S, Haque M. Metformin: a review of potential mechanism and therapeutic utility beyond diabetes. Drug Des Devel Ther. 2023, 17:1907-32. 10.2147\/DDDT.S409373","journal-title":"Drug Des Devel Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2013.02.006","article-title":"Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes","volume":"39","author":"Scheen AJ","year":"2013","unstructured":"Scheen AJ, Paquot N. Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes. Diabetes Metab. 2013, 39:179-90. 10.1016\/j.diabet.2013.02.006","journal-title":"Diabetes Metab"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00127-017-1408-7","article-title":"Nightmares in the general population: identifying potential causal factors","volume":"52","author":"Rek S","year":"2017","unstructured":"Rek S, Sheaves B, Freeman D. Nightmares in the general population: identifying potential causal factors. Soc Psychiatry Psychiatr Epidemiol. 2017, 52:1123-33. 10.1007\/s00127-017-1408-7","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jsr.12820","article-title":"Aetiology and treatment of nightmare disorder: State of the art and future perspectives","volume":"28","author":"Gieselmann A","year":"2019","unstructured":"Gieselmann A, Ait Aoudia M, Carr M, et al.. Aetiology and treatment of nightmare disorder: State of the art and future perspectives. J Sleep Res. 2019, 28:10.1111\/jsr.12820","journal-title":"J Sleep Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1819.2007.01789.x","article-title":"Nightmare disorder, dream anxiety, and subjective sleep quality in patients with borderline personality disorder","volume":"62","author":"Semiz UB","year":"2008","unstructured":"Semiz UB, Basoglu C, Ebrinc S, Cetin M. Nightmare disorder, dream anxiety, and subjective sleep quality in patients with borderline personality disorder. Psychiatry Clin Neurosci. 2008, 62:48-55. 10.1111\/j.1440-1819.2007.01789.x","journal-title":"Psychiatry Clin Neurosci"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4103\/jod.jod_22_21","article-title":"An unusual side effect of metformin - nightmare and abnormal dreams","volume":"12","author":"Agrawal PK","year":"2021","unstructured":"Agrawal PK, Gautam A, Pursnani N, Parihar A, Singh B. An unusual side effect of metformin - nightmare and abnormal dreams. J Diabetol. 2021, 12:530-2. 10.4103\/jod.jod_22_21","journal-title":"J Diabetol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1002\/hup.465","article-title":"Drug induced nightmares - an etiology based review","volume":"18","author":"Pagel JF","year":"2003","unstructured":"Pagel JF, Helfter P. Drug induced nightmares - an etiology based review. Hum Psychopharmacol. 2003, 18:59-67. 10.1002\/hup.465","journal-title":"Hum Psychopharmacol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1345\/aph.18150","article-title":"Drug-induced nightmares","volume":"33","author":"Thompson DF","year":"1999","unstructured":"Thompson DF, Pierce DR. Drug-induced nightmares. Ann Pharmacother. 1999, 33:93-8. 10.1345\/aph.18150","journal-title":"Ann Pharmacother"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.28974","article-title":"An unusual association between metformin and nightmares: a case report","volume":"14","author":"Voloshyna D","year":"2022","unstructured":"Voloshyna D, Sandhu QI, Khan S, et al.. An unusual association between metformin and nightmares: a case report. Cureus. 2022, 14:10.7759\/cureus.28974","journal-title":"Cureus"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/7809305","article-title":"Nightmare and abnormal dreams: rare side effects of metformin","volume":"2018","author":"Yanto TA","year":"2018","unstructured":"Yanto TA, Huang I, Kosasih FN, Lugito NP. Nightmare and abnormal dreams: rare side effects of metformin. Case Rep Endocrinol. 2018, 2018:10.1155\/2018\/7809305","journal-title":"Case Rep Endocrinol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/266434-metformin-induced-nightmares-an-uncommon-event","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T15:45:26Z","timestamp":1720626326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/266434-metformin-induced-nightmares-an-uncommon-event"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,10]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.64251","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,10]]}}}